[HTML][HTML] Lipoprotein (a): biology and clinical importance
SPA McCormick - The Clinical Biochemist Reviews, 2004 - ncbi.nlm.nih.gov
Abstract Lipoprotein (a)[Lp (a)] is a unique lipoprotein that has emerged as an independent
risk factor for developing vascular disease. Plasma Lp (a) levels above the common cut-off …
risk factor for developing vascular disease. Plasma Lp (a) levels above the common cut-off …
[HTML][HTML] The role of Lipoprotein (a) in cardiovascular disease: Current concepts and future perspectives
Abstract High lipoprotein (a)[Lp (a)] levels are associated with the development of
atherosclerotic cardiovascular disease (ASCVD) and with calcific aortic valve stenosis …
atherosclerotic cardiovascular disease (ASCVD) and with calcific aortic valve stenosis …
Lipoprotein (a): new insights into mechanisms of atherogenesis and thrombosis
A Deb, NM Caplice - Clinical cardiology, 2004 - Wiley Online Library
Abstract Lipoprotein (a)(Lp [a]) continues to be a controversial molecule regarding its role in
human vascular disease. Although the physiologic role of this molecule is still unclear, novel …
human vascular disease. Although the physiologic role of this molecule is still unclear, novel …
Lipoprotein (a): when to measure and how to treat?
D Rhainds, MR Brodeur, JC Tardif - Current Atherosclerosis Reports, 2021 - Springer
Abstract Purpose of Review The purpose of this article is to review current evidence for
lipoprotein (a)(Lp (a)) as a risk factor for multiple cardiovascular (CV) disease phenotypes …
lipoprotein (a)(Lp (a)) as a risk factor for multiple cardiovascular (CV) disease phenotypes …
Lipoprotein (a) in health and disease
F Kronenberg, A Steinmetz, GM Kostner… - Critical reviews in …, 1996 - Taylor & Francis
Abstract Lipoprotein (a)[Lp (a)] represents an LDL-like particle to which the Lp (a)-specific
apolipoprotein (a) is linked via a disulfide bridge. It has gained considerable interest as a …
apolipoprotein (a) is linked via a disulfide bridge. It has gained considerable interest as a …
Lipoprotein (a): Knowns, unknowns and uncertainties
M Ruscica, CR Sirtori, A Corsini, GF Watts… - Pharmacological …, 2021 - Elsevier
Over the last 10 years, there have been advances on several aspects of lipoprotein (a)
which are reviewed in the present article. Since the standard immunoassays for measuring …
which are reviewed in the present article. Since the standard immunoassays for measuring …
The renaissance of lipoprotein (a): brave new world for preventive cardiology?
Abstract Lipoprotein (a)[Lp (a)] is a highly heritable cardiovascular risk factor. Although
discovered more than 50 years ago, Lp (a) has recently re-emerged as a major focus in the …
discovered more than 50 years ago, Lp (a) has recently re-emerged as a major focus in the …
Lipoprotein (a) and cardiovascular disease in Chinese population: a Beijing heart society expert scientific statement
JJ Li, CS Ma, D Zhao, XW Yan - JACC: Asia, 2022 - jacc.org
Elevated concentration of lipoprotein (a)[Lp (a)] is an independent risk factor for
atherosclerotic cardiovascular disease, including coronary artery disease, stroke, peripheral …
atherosclerotic cardiovascular disease, including coronary artery disease, stroke, peripheral …
Lipoprotein (a) in cardiovascular diseases
M Malaguarnera, M Vacante, C Russo… - BioMed research …, 2013 - Wiley Online Library
Lipoprotein (a)(Lp (a)) is an LDL‐like molecule consisting of an apolipoprotein B‐100 (apo
(B‐100)) particle attached by a disulphide bridge to apo (a). Many observations have …
(B‐100)) particle attached by a disulphide bridge to apo (a). Many observations have …
Lipoprotein (a) and long-term cardiovascular risk in a multi-ethnic pooled prospective cohort
Abstract Background Lipoprotein (a)(Lp [a]) is a causal genetic risk factor for atherosclerotic
cardiovascular disease (ASCVD). There are limited long-term follow-up data from large US …
cardiovascular disease (ASCVD). There are limited long-term follow-up data from large US …